Importantly, analysis result of TCGA showed that FOXD2-AS1 expression was significantly elevated in recurrent thyroid cancer tissues compared with those in non-recurrent thyroid cancer tissues (Figure 1C), and high expression of FOXD2-AS1 predicted poor recurrence-free survivals (Figure 1D). Here, FOXD2 is linked to thyroid cancer.